claimtoken-539efc0fe87b4 Back in March I made a note to myself to write a paper – or, more likely, a blog post – presenting a taxonomy of behavioural interventions. I had gotten tired of everything being called a ‘nudge’ and with debates… Read More »A taxonomy of behavioural interventions
It was recently proposed that, here in the UK, foreigners should start having to pay towards their health care because of the apparent budgetary pressure from ‘health tourists’. Let’s be clear upfront; this isn’t a problem. If you believe the media, ‘health tourism’… Read More »No borders, no nations, no user charges
I recently signed up for a clinical trial (www.intervalstudy.org.uk). The baseline questionnaire included the SF-36. Under normal circumstances I would be at full health for all questions but, on this occasion, I was not. If the researchers go on to… Read More »The economics of bereavement
Personalised medicine appears to be an inevitable future of health care, and economists aren’t ready for it. It has various monikers and related concepts including precision medicine, stratified medicine, pharmacogenomics, pharmacogenetics and predictive medicine. But, whatever you call it, it means big… Read More »Economics of personalised medicine: an introduction
Economics is largely about trade-offs and compromise. Academics study the former but don’t often engage in the latter. In health economics, as in other fields, a key trade-off is between equity and efficiency. We’ve been studying this for a.very.long.time. Despite this, as… Read More »The potential of the super QALY to reconcile the key contentions in health economics
An argument that often comes up when it comes to the distribution of scarce health resources is who should receive them. Many different arguments are posed with varying degrees of sophistication. Various studies have elicited population preferences for distributing scarce… Read More »To whom the benefits?
Why should we consider health equity? The rationale for treating health as a special good rests on the idea that a certain level of health is a precondition for achieving any of the other outcomes in life that we value.… Read More »The role of healthcare in promoting health equity
Can we reasonably consider ‘doing nothing’ as an alternative course of action? In many cost-effectiveness analyses the intervention under consideration is compared against a ‘doing nothing’ scenario, although frequently the next best alternative is used. Ultimately the health technology assessment… Read More »The ethics of doing nothing
I’m sure many of you are familiar with the process of seeking ethical approval for a project. In my opinion there is not enough of an explicit link between the potential value of a trial and its likelihood of receiving… Read More »Expected value of ethical approval?